Defibrillators, Implantable
24
4
4
12
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
8.3%
2 terminated out of 24 trials
85.7%
-0.8% vs benchmark
8%
2 trials in Phase 3/4
25%
3 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (24)
Conduction System Pacing and AV Junction Ablation in Heart Failure With Atrial Fibrillation (SYNC AF-HTx)
Correct Mobilization Time After Implantation of an Intracardiac Electronic Device Implantation
DATAS: The Dual Chamber & Atrial Tachyarrhythmias Adverse Events Study
Remote Programming of Cardiac Implantable Electronic Device
Slew Rate As a Predictor for Optimal Lead Fixation
French COhoRte Extra-Vascular Implantable CardiovErter DefibrillatoR
Prospective Köln Bonn Registry for the Extraction of Pacmaker and ICD Leads
Human Care Model-Based Nursing Interventions on Psychosocial Adjustment
Evaluation of the " Tele-follow-up " for the Follow-up of Implantable Defibrillators
Physical Activity and Ventricular Arrhythmias
Acute Effect of One Single Bout of High Intensity Exercise on the Tendency for Ventricular Arrhythmia
Precision Event Monitoring for Patients With Heart Failure Using HeartLogic
Patient Expectations After Implantable-cardioverter Defibrillator (ICD) Implantation
Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Patients With Ventricular Tachycardia
International Electrical Storm Registry
Precise Measurement of Pediatric Defibrillation Thresholds
Electrical Safety of Implantable Cardioverter Defibrillators
Multi-centre Observational Registry on Patients With Implantable Devices Remotely Monitored
PET / CT With 18F-FDG: Does it Optimize the I 123-MIBG Imaging Results in the Search for Discriminating Factors for the Implementation of an Implantable Defibrillator?
Omega 3 Polyunsaturated Fatty Acid Supplements (PUFAs) and Microvolt T Wave Alternans (TWA) in Patients With Ventricular Arrhythmia